

Eli Lilly's Alzheimer’s Drug Donanemab Receives Unanimous FDA Advisory Panel Recommendation
Eli Lilly and Company, a global healthcare leader, has achieved a significant milestone with its Alzheimer’s drug, donanemab. On June 11, 2


Daily Market Review: Nikkei 225 Growth, CrowdStrike Surge, Natural Gas Value, and USD Strength
In today's market review, we delve into significant developments impacting major indices, stocks, commodities, and currencies. Key highli...
.png)
.jpg)





























.jpg)











%20(970%20%C3%97%20145%20px.jpg)